Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors - Hémodynamique, Interaction Fibrose et Invasivité Tumorales Hépatiques Accéder directement au contenu
Article Dans Une Revue Therapeutic Advances in Medical Oncology Année : 2020

Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors

Résumé

Metastatic pancreatic ductal adenocarcinomas (PDACs) are now more effectively controlled using chemotherapy combinations such as FOLFIRINOX and gemcitabine plus nab-paclitaxel (NabP) regimens with a subset of patients who achieve a sustained tumor stabilization or response. The next challenge is to design maintenance therapies that result in continued tumor control with minimal toxicity. Quality of life should always be a priority in these patients with prolonged survival. Gradually tapering off the intensity of chemotherapy by suppressing drug(s) in the combination is one option. Thus, maintenance with 5-fluorouracil or gemcitabine as single agents after FOLFIRINOX or gemcitabine-NabP induction, respectively, seems to be a promising approach to minimize neurotoxicity while maintaining efficacy. Another option is to introduce maintenance drug(s) with different anti-tumoral actions. The recent example of olaparib in patients with BRCA mutated PDAC provides a promising proof-of-concept of a switch maintenance strategy in this setting.
Fichier principal
Vignette du fichier
10.1177_1758835920937949.pdf (699.85 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
licence : CC BY NC - Paternité - Pas d'utilisation commerciale

Dates et versions

hal-03285853 , version 1 (07-06-2023)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Pascal Hammel, Carole Vitellius, Émeric Boisteau, Mathilde Wisniewski, Elise Colle, et al.. Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors. Therapeutic Advances in Medical Oncology, 2020, 12, pp.175883592093794. ⟨10.1177/1758835920937949⟩. ⟨hal-03285853⟩
54 Consultations
18 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More